Relmada Therapeutics Announces Q2 2025 Financial Results Call

Author: Hannah Lewis Updated: 07-31-2025 07:21 AM

Relmada Therapeutics Plans Financial Results Discussion

Relmada Therapeutics, Inc. (NASDAQ: RLMD), a company dedicated to transforming the landscape of oncology and central nervous system treatments, is excited to announce an upcoming conference call to discuss its financial results for the second quarter of 2025. This event is scheduled for Thursday, at 4:30 PM ET.

Conference Call and Webcast Details

The conference call will be accessible to both participants in the US and international investors. The US participant dial-in number will be 1-877-407-0792, while participants dialing in from outside the US can reach 1-201-689-8263. The conference ID is 13754263. If you prefer to access the call via the internet, there will be a webcast available for listeners.

Webcast Access Information

To join the live call, individuals can access the webcast on Relmada's official website. A replay of the event will also be available shortly after the conclusion of the call in the Investors section.

About Relmada Therapeutics

Relmada Therapeutics is committed to developing groundbreaking therapies to address serious conditions faced by patients today. With key candidates such as NDV-01 and sepranolone progressing through clinical trials, the company aims to meet significant unmet medical needs.

Focus on Innovation in Biotechnology

With each advancement in their clinical pipeline, Relmada Therapeutics demonstrates a steadfast commitment to innovation. Their research primarily targets central nervous system disorders and various oncology indications, reinforcing their role as a leader in biotech innovation.

Investor and Media Relations

As part of their investor outreach, Relmada aims to ensure transparency and open communication. Investors seeking more information can find additional details on their official website. For inquiries, Brian Ritchie from LifeSci Advisors is available for investor-related questions. Media representatives can reach out through the corporate communications team, ensuring all inquiries are addressed.

Frequently Asked Questions

What is the purpose of the conference call?

The call aims to discuss Relmada Therapeutics' financial results for the second quarter and recent advancements in their pharmaceutical development.

How can I participate in the conference call?

Participants can dial in through the specified numbers or access the call via the provided webcast link.

What are Relmada's main therapeutic candidates?

Relmada focuses on key candidates such as NDV-01 and sepranolone, designed to treat oncology-related and central nervous system conditions.

Where can I find more information about Relmada Therapeutics?

Further details can be found on their official website, where updates about financial results and corporate activities are regularly posted.

Who should I contact for media inquiries?

Media inquiries can be directed to Relmada's corporate communications team via the email provided for media relations.

About The Author

Hi there, I'm Hannah Lewis, a writer and financial specialist of 36 years old committed to making money understandable and approachable to everyone. Years of working in the field have given me a thorough grasp of market trends, investment techniques, and economic fundamentals. My objective is to enable people, by means of understandable, useful guidance, to take charge of their financial destiny.

I have written many articles for financial blogs over my career that simplify difficult financial ideas into understandable insights. Being financially literate is a critical ability, and I am passionate about enabling people to confidently manage their financial lives. Regardless of your level of experience, my work will help you at every stage of the investment process. I appreciate being allowed to share in your success and financial expansion.

Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.